Therapeutic options for peritoneal metastasis arising from colorectal cancer

URN to cite this document:: urn:nbn:de:bvb:355-epub-415152
DOI to cite this document:: 10.5283/epub.41515

Glockzin, Gabriel ; Schlitt, Hans J.

; Piso, Pompiliu

Preview

License: Creative Commons Attribution Non-commercial 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 17 Feb 2020 13:41

Alternative links to fulltext:DOI Pubmed Central Pubmed

Details

Preview

Export bibliographical data

Abstract

Peritoneal metastasis is a common sign of advanced tumor stage, tumor progression or tumor recurrence in patients with colorectal cancer. Due to the improvement of systemic chemotherapy, the development of targeted therapy and the introduction of additive treatment options such as cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), the therapeutic approach to ...